Proteomics to Study Candida albicans Biology and Pathogenicity

E-ISSN： 2212-3989|6|4|335-341

ISSN： 1871-5265

Source： Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol.6, Iss.4, 2006-12, pp. : 335-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aspartic Protease Inhibitors as Potential Anti-Candida albicans Drugs: Impacts on Fungal Biology, Virulence and Pathogenesis

Current Medicinal Chemistry, Vol. 18, Iss. 16, 2011-06 ,pp. : 2401-2419

Bentham Science Publishers

Access to resources Recommend Favorite

Betamethasone/prednisolone: Candida albicans colitis: case report

Reactions Weekly, Vol. 1, Iss. 1337, 2011-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Antifungals to treat Candida albicans

By Moudgal Varsha Sobel Jack

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 12, 2010-08 ,pp. : 2037-2048

Informa Healthcare

Access to resources Recommend Favorite

Current approaches to the treatment of Candida albicans infections

By Burt E.T.

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 2, 2001-02 ,pp. : 269-282

Informa Healthcare

Access to resources Recommend Favorite

A Comparative In Vitro Study of Two Denture Cleaning Techniques as an Effective Strategy for Inhibiting Candida albicans Biofilms on Denture Surfaces and Reducing Inflammation

By Ramage Gordon Zalewska Adriana Cameron Donald A. Sherry Leighann Murray Colin Finnegan Mary Beth Loewy Zvi G. Jagger Daryll C.

Journal of Prosthodontics, Vol. 21, Iss. 7, 2012-10 ,pp. : 516-522

Blackwell Publishing

Access to resources Recommend Favorite